PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmcurolBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Urology
 
BMC Urol. 2012; 12: 18.
Published online Jun 13, 2012. doi:  10.1186/1471-2490-12-18
PMCID: PMC3424138
Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of Bladder Cancer
Sabrina Thalita Reis,1,2 Katia Ramos M Leite,1 Luís Felipe Piovesan,2 José Pontes-Junior,1,2 Nayara Izabel Viana,1 Daniel Kanda Abe,1,2 Alexandre Crippa,2 Caio Martins Moura,1 Sanarelly Pires Adonias,2 Miguel Srougi,1,2 and Marcos Francisco Dall’Ogliocorresponding author1,2
1Laboratory of Medical Investigation (LIM55), Urology Department, University of Sao Paulo Medical School, Sao Paulo, Brazil
2Uro-Oncology Group, Urology Department, University of Sao Paulo Medical School and Institute of Cancer of State of Sao Paulo (ICESP), Sao Paulo, Brazil
corresponding authorCorresponding author.
Sabrina Thalita Reis: sasareis/at/gmail.com; Katia Ramos M Leite: katiaramos/at/uol.com.br; Luís Felipe Piovesan: lfpiovesan/at/gmail.com; José Pontes-Junior: docjpjr/at/uol.com.br; Nayara Izabel Viana: nayara_viana_2/at/hotmail.com; Daniel Kanda Abe: abe.daniel/at/gmail.com; Alexandre Crippa: drcrippa/at/uol.com.br; Caio Martins Moura: caiobiologia/at/hotmail.com; Sanarelly Pires Adonias: sanarelly/at/gmail.com; Miguel Srougi: srougi/at/uol.com.br; Marcos Francisco Dall’Oglio: urologiamfd/at/uol.com.br
Received January 23, 2012; Accepted June 13, 2012.
Abstract
Background
Extracellular matrix homeostasis is strictly maintained by a coordinated balance between the expression of metalloproteinases (MMPs) and their inhibitors. The purpose of this study was to investigate whether the expression of MMP-9, MMP-2 and its specific inhibitors, are expressed in a reproducible, specific pattern and if the profiles are related to prognosis in Bladder Cancer (BC).
Methods
MMP-9, MMP-2 and its specific inhibitors expression levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) in fresh-frozen malignant tissue collected from 40 patients with BC submitted to transurethral resection of bladder. The control group consisted of normal bladder tissue from five patients who had undergone retropubic prostatectomy to treat benign prostatic hyperplasia.
Results
MMP-9 was overexpressed in 59.0 % of patients, and MMP-2, TIMP-1, TIMP-2, MMP-14, RECK and IL-8 was underexpressed in most of the patients. Regarding prognostic parameters we observed that high-grade tumors exhibited significantly higher levels of MMP-9 and IL-8 (p = 0.012, p = 0.003). Invasive tumors (pT1-pT2) had higher expression levels of MMP-9 than superficial tumors (pTa) (p = 0.026). The same was noted for IL-8 that was more expressed by invasive tumors (p = 0.015, p = 0.048). Most importantly tumor recurrence was related with higher levels of both MMP-9 (p = 0.003) and IL-8 (p = 0.005).
Conclusion
We have demonstrated that the overexpression of MMP-9 and higher expression of IL-8 are related to unfavorable prognostic factors of urothelial bladder cancer and tumor recurrence and may be useful in the follow up of the patients.
Keywords: Bladder cancer, Matrix metalloproteinase, Prognosis, Diagnosis, Gene expression
Articles from BMC Urology are provided here courtesy of
BioMed Central